Log in to save to my catalogue

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196837

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

About this item

Full title

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-04, Vol.117 (17), p.9490-9496

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was tra...

Alternative Titles

Full title

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196837

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196837

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2004168117

How to access this item